BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 33833397)

  • 1. CCL8 mediates crosstalk between endothelial colony forming cells and triple-negative breast cancer cells through IL-8, aggravating invasion and tumorigenicity.
    Kim ES; Nam SM; Song HK; Lee S; Kim K; Lim HK; Lee H; Kang KT; Kwon YJ; Chun YJ; Park SY; Jung J; Moon A
    Oncogene; 2021 May; 40(18):3245-3259. PubMed ID: 33833397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Angiogenic Responses of Human Endothelial Colony-Forming Cells to Different Molecular Subtypes of Breast Cancer Cells.
    Lee H; Kang KT
    J Lipid Atheroscler; 2021 Jan; 10(1):111-122. PubMed ID: 33537258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-Stroma-Inflammation Networks Promote Pro-metastatic Chemokines and Aggressiveness Characteristics in Triple-Negative Breast Cancer.
    Liubomirski Y; Lerrer S; Meshel T; Rubinstein-Achiasaf L; Morein D; Wiemann S; Körner C; Ben-Baruch A
    Front Immunol; 2019; 10():757. PubMed ID: 31031757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
    Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
    J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COL8A1 enhances the invasion/metastasis in MDA-MB-231 cells via the induction of IL1B and MMP1 expression.
    Sagara A; Miura S; Kobinata A; Naganawa R; Yaginuma S; Saito S; Saito R; Kominato H; Yumoto T; Sato F
    Biochem Biophys Res Commun; 2023 Jan; 642():145-153. PubMed ID: 36577251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A.
    Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK
    BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous blockade of IL-6 and CCL5 signaling for synergistic inhibition of triple-negative breast cancer growth and metastasis.
    Jin K; Pandey NB; Popel AS
    Breast Cancer Res; 2018 Jun; 20(1):54. PubMed ID: 29898755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Notch-Mediated Tumor-Stroma-Inflammation Networks Promote Invasive Properties and CXCL8 Expression in Triple-Negative Breast Cancer.
    Liubomirski Y; Lerrer S; Meshel T; Morein D; Rubinstein-Achiasaf L; Sprinzak D; Wiemann S; Körner C; Ehrlich M; Ben-Baruch A
    Front Immunol; 2019; 10():804. PubMed ID: 31105691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human adipose tissue-derived stromal/stem cells promote migration and early metastasis of triple negative breast cancer xenografts.
    Rowan BG; Gimble JM; Sheng M; Anbalagan M; Jones RK; Frazier TP; Asher M; Lacayo EA; Friedlander PL; Kutner R; Chiu ES
    PLoS One; 2014; 9(2):e89595. PubMed ID: 24586900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokines secreted from adipose tissues mediate tumor proliferation and metastasis in triple negative breast cancer.
    Zhang K; Chen L; Zheng H; Zeng Y
    BMC Cancer; 2022 Aug; 22(1):886. PubMed ID: 35964108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FGF13 promotes metastasis of triple-negative breast cancer.
    Johnstone CN; Pattison AD; Harrison PF; Powell DR; Lock P; Ernst M; Anderson RL; Beilharz TH
    Int J Cancer; 2020 Jul; 147(1):230-243. PubMed ID: 31957002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymoquinone Inhibits Proliferation and Migration of MDA-MB-231 Triple Negative Breast Cancer Cells by Suppressing Autophagy, Beclin-1 and LC3.
    Ünal TD; Hamurcu Z; Delibaşı N; Çınar V; Güler A; Gökçe S; Nurdinov N; Ozpolat B
    Anticancer Agents Med Chem; 2021; 21(3):355-364. PubMed ID: 32767958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-200c/PAI-2 promotes the progression of triple negative breast cancer via M1/M2 polarization induction of macrophage.
    Meng Z; Zhang R; Wang Y; Zhu G; Jin T; Li C; Zhang S
    Int Immunopharmacol; 2020 Apr; 81():106028. PubMed ID: 31801690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMGA1 promotes breast cancer angiogenesis supporting the stability, nuclear localization and transcriptional activity of FOXM1.
    Zanin R; Pegoraro S; Ros G; Ciani Y; Piazza S; Bossi F; Bulla R; Zennaro C; Tonon F; Lazarevic D; Stupka E; Sgarra R; Manfioletti G
    J Exp Clin Cancer Res; 2019 Jul; 38(1):313. PubMed ID: 31311575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tryptophan hydroxylase 1 and 5-HT
    Gautam J; Banskota S; Regmi SC; Ahn S; Jeon YH; Jeong H; Kim SJ; Nam TG; Jeong BS; Kim JA
    Mol Cancer; 2016 Nov; 15(1):75. PubMed ID: 27871326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain-derived neurotrophic factor (BDNF) -TrKB signaling modulates cancer-endothelial cells interaction and affects the outcomes of triple negative breast cancer.
    Tsai YF; Tseng LM; Hsu CY; Yang MH; Chiu JH; Shyr YM
    PLoS One; 2017; 12(6):e0178173. PubMed ID: 28604807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenylmethimazole and a thiazole derivative of phenylmethimazole inhibit IL-6 expression by triple negative breast cancer cells.
    Noori MS; O'Brien JD; Champa ZJ; Deosarkar SP; Lanier OL; Qi C; Burdick MM; Schwartz FL; Bergmeier SC; McCall KD; Goetz DJ
    Eur J Pharmacol; 2017 May; 803():130-137. PubMed ID: 28343970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosomal MMP-1 transfers metastasis potential in triple-negative breast cancer through PAR1-mediated EMT.
    Zhu Y; Tao Z; Chen Y; Lin S; Zhu M; Ji W; Liu X; Li T; Hu X
    Breast Cancer Res Treat; 2022 May; 193(1):65-81. PubMed ID: 35254603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bazedoxifene is a novel IL-6/GP130 inhibitor for treating triple-negative breast cancer.
    Tian J; Chen X; Fu S; Zhang R; Pan L; Cao Y; Wu X; Xiao H; Lin HJ; Lo HW; Zhang Y; Lin J
    Breast Cancer Res Treat; 2019 Jun; 175(3):553-566. PubMed ID: 30852762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crosstalk between stromal components and tumor cells of TNBC via secreted factors enhances tumor growth and metastasis.
    Jin K; Pandey NB; Popel AS
    Oncotarget; 2017 Sep; 8(36):60210-60222. PubMed ID: 28947965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.